Results 141 to 150 of about 20,149 (199)

Long-Term Follow-Up of Patients With Short QT Syndrome: Clinical Profile and Outcome. [PDF]

J Am Heart Assoc, 2018
El-Battrawy I, Besler J, Liebe V, Schimpf R, Tülümen E, Rudic B, Lang S, Wolpert C, Zhou X, Akin I, Borggrefe M.   +10 more
europepmc   +1 more source

Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. [PDF]

Front Pharmacol, 2020
Lan H, Xu Q, El-Battrawy I, Zhong R, Li X, Lang S, Cyganek L, Borggrefe M, Zhou X, Akin I.   +9 more
europepmc   +1 more source

Early Repolarization is Associated with Short QT Syndrome in Italian Cohort

Annals of Global Health, 2017
E. Rawick, D. Nevelev, S. Nevelev, A. Mazzanti, S. Priori   +4 more
doaj   +1 more source

Correction: Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria. [PDF]

PLoS Comput Biol, 2019
PLOS Computational Biology Staff.
europepmc   +1 more source

Modelling the effects of chloroquine on KCNJ2-linked short QT syndrome. [PDF]

Oncotarget, 2017
Luo C, Wang K, Zhang H.
europepmc   +1 more source

Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome. [PDF]

Heliyon, 2019
Butler A, Zhang Y, Stuart AG, Dempsey CE, Hancox JC.   +4 more
europepmc   +1 more source

Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome. [PDF]

HeartRhythm Case Rep, 2019
Farag MJ, Atallah J.
europepmc   +1 more source

Familial short QT syndrome [PDF]

, 2020
openaire   +1 more source

Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. [PDF]

J Am Heart Assoc, 2018
El-Battrawy I, Lan H, Cyganek L, Zhao Z, Li X, Buljubasic F, Lang S, Yücel G, Sattler K, Zimmermann WH, Utikal J, Wieland T, Ravens U, Borggrefe M, Zhou XB, Akin I.   +15 more
europepmc   +1 more source